Zalcitabine
Back to searchMolecule Structure
Scientific Name
Zalcitabine
Description of the Drug
Zalcitabine is a dideoxynucleoside used to treat HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00943
http://www.drugbank.ca/drugs/DB00943
Brand Name(s)
Hivid
Company Owner(s)
Hoffmann La Roche Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3598 | ||||
PharmGKB | PA451950 | ||||
Human Metabolome Database | HMDB0015078 | ||||
DrugBank | DB00943 | ||||
PubChem: Thomson Pharma | 14797711 | 15171927 | |||
PubChem | 24066 | ||||
Mcule | MCULE-6071296177 | ||||
LINCS | LSM-5915 | ||||
Nikkaji | J277.119E | ||||
BindingDB | 50145605 | ||||
EPA CompTox Dashboard | DTXSID0023747 | ||||
DrugCentral | 2856 | ||||
Brenda | 2378 | 153423 | 165907 | 51598 | 154412 |
ChemicalBook | CB2369466 | ||||
Guide to Pharmacology | 4828 | ||||
rxnorm | ZALCITABINE | ||||
KEGG Ligand | C07207 | ||||
ChEBI | 10101 | ||||
ZINC | ZINC000000039906 |